In fiscal 2025, which ended May 31, 2025, Exousia Bio, Inc. used $4,528 of cash from operations, up 63.7% from the year before.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2026
Feb 28, 2026
|
FY 2025
May 31, 2025
|
FY 2024
May 31, 2024
|
FY 2023
May 31, 2023
|
|---|---|---|---|---|
| Operating | ||||
| Depreciation and amortization |
0
-51.7%
|
0
-25.0%
|
0
+0.0%
|
0
|
| Operating cash flow |
0
+0.5%
|
-0
+63.7%
|
-0
+67.2%
|
-0
|
| Investing | ||||
| Investing cash flow |
-22
|
0
|
0
|
0
|
| Financing | ||||
| Financing cash flow |
22
+25903.1%
|
0
-38.1%
|
0
-84.2%
|
0
|
| Ratios | ||||
| Cash conversion |
—
|
-0.09x
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Services-Educational Services (SIC 8200)
- Listed as
- LMMY (OTC)
- Fiscal year ends
- May 31
- Incorporated in
- WY
- Headquarters
- St. Petersburg, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1939937
- Former names
- LAMY (until Jan 15, 2026); L A M Y (until Apr 15, 2024)
Other Services-Educational Services companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.